123 related articles for article (PubMed ID: 8841971)
1. Tau protein and apolipoprotein E in CSF diagnostics of Alzheimer's disease: impact on non Alzheimer's dementia?
Rösler N; Wichart I; Bancher C; Jellinger KA
J Neural Transm Suppl; 1996; 47():259-66. PubMed ID: 8841971
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of neurobiochemical profiles in the lumbar cerebrospinal fluid of Alzheimer's disease patients.
Rösler N; Wichart I; Jellinger KA
J Neural Transm (Vienna); 2001; 108(2):231-46. PubMed ID: 11314776
[TBL] [Abstract][Full Text] [Related]
3. Tau and apo E in CSF: potential aid for discriminating Alzheimer's disease from other dementias.
Molina L; Touchon J; Herpé M; Lefranc D; Duplan L; Cristol JP; Sabatier R; Vermersch P; Pau B; Mourton-Gilles C
Neuroreport; 1999 Nov; 10(17):3491-5. PubMed ID: 10619631
[TBL] [Abstract][Full Text] [Related]
4. A population-based study of tau protein and ubiquitin in cerebrospinal fluid in 85-year-olds: relation to severity of dementia and cerebral atrophy, but not to the apolipoprotein E4 allele.
Skoog I; Vanmechelen E; Andreasson LA; Palmertz B; Davidsson P; Hesse C; Blennow K
Neurodegeneration; 1995 Dec; 4(4):433-42. PubMed ID: 8846237
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study.
Andreasen N; Vanmechelen E; Van de Voorde A; Davidsson P; Hesse C; Tarvonen S; Räihä I; Sourander L; Winblad B; Blennow K
J Neurol Neurosurg Psychiatry; 1998 Mar; 64(3):298-305. PubMed ID: 9527138
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid apolipoprotein E is reduced in Alzheimer's disease.
Blennow K; Hesse C; Fredman P
Neuroreport; 1994 Dec; 5(18):2534-6. PubMed ID: 7696597
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
8. Intra vitam lumbar cerebrospinal fluid and serum and postmortem ventricular immunoreactive apolipoprotein E in patients with Alzheimer's disease.
Rösler N; Wichart I; Jellinger KA
J Neurol Neurosurg Psychiatry; 1996 Apr; 60(4):452-4. PubMed ID: 8774418
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E4 accelerates dementia and increases cerebrospinal fluid tau levels in Alzheimer's disease.
Kanai M; Shizuka M; Urakami K; Matsubara E; Harigaya Y; Okamoto K; Shoji M
Neurosci Lett; 1999 May; 267(1):65-8. PubMed ID: 10400250
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E in cerebrospinal fluid from patients with Alzheimer's disease and other forms of dementia is reduced but without any correlation to the apoE4 isoform.
Landén M; Hesse C; Fredman P; Regland B; Wallin A; Blennow K
Dementia; 1996; 7(5):273-8. PubMed ID: 8872419
[TBL] [Abstract][Full Text] [Related]
11. Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer's Disease.
Johansson P; Almqvist EG; Bjerke M; Wallin A; Johansson JO; Andreasson U; Blennow K; Zetterberg H; Svensson J
J Alzheimers Dis; 2017; 59(3):1017-1026. PubMed ID: 28697566
[TBL] [Abstract][Full Text] [Related]
12. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
[TBL] [Abstract][Full Text] [Related]
13. Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer's Disease.
Zimetti F; Caffarra P; Ronda N; Favari E; Adorni MP; Zanotti I; Bernini F; Barocco F; Spallazzi M; Galimberti D; Ricci C; Ruscica M; Corsini A; Ferri N
J Alzheimers Dis; 2017; 55(1):315-320. PubMed ID: 27662294
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid levels of a 20-22 kDa NH2 fragment of human tau provide a novel neuronal injury biomarker in Alzheimer's disease and other dementias.
Amadoro G; Corsetti V; Sancesario GM; Lubrano A; Melchiorri G; Bernardini S; Calissano P; Sancesario G
J Alzheimers Dis; 2014; 42(1):211-26. PubMed ID: 24851856
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E genotyping and cerebrospinal fluid tau protein: implications for the clinical diagnosis of Alzheimer's disease.
Arai H; Higuchi S; Sasaki H
Gerontology; 1997; 43 Suppl 1():2-10. PubMed ID: 9187933
[TBL] [Abstract][Full Text] [Related]
16. Increasing cerebrospinal fluid tau levels in a subgroup of Alzheimer patients with apolipoprotein E allele epsilon 4 during 14 months follow-up.
Blomberg M; Jensen M; Basun H; Lannfelt L; Wahlund LO
Neurosci Lett; 1996 Aug; 214(2-3):163-6. PubMed ID: 8878109
[TBL] [Abstract][Full Text] [Related]
17. Tau protein in cerebrospinal fluid from semantic dementia patients.
Andersen C; Froelich Fabre S; Ostberg P; Lannfelt L; Wahlund L
Neurosci Lett; 2000 Nov; 294(3):155-8. PubMed ID: 11072138
[TBL] [Abstract][Full Text] [Related]
18. High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype.
Galasko D; Chang L; Motter R; Clark CM; Kaye J; Knopman D; Thomas R; Kholodenko D; Schenk D; Lieberburg I; Miller B; Green R; Basherad R; Kertiles L; Boss MA; Seubert P
Arch Neurol; 1998 Jul; 55(7):937-45. PubMed ID: 9678311
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid apolipoprotein E (apoE) levels in Alzheimer's disease patients are increased at follow up and show a correlation with levels of tau protein.
Lindh M; Blomberg M; Jensen M; Basun H; Lannfelt L; Engvall B; Scharnagel H; März W; Wahlund LO; Cowburn RF
Neurosci Lett; 1997 Jun; 229(2):85-8. PubMed ID: 9223597
[TBL] [Abstract][Full Text] [Related]
20. Clinical indications for analysis of Alzheimer's disease CSF biomarkers.
Engelborghs S
Rev Neurol (Paris); 2013 Oct; 169(10):709-14. PubMed ID: 24016466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
